Takara Bio Inc banner

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 147 JPY 0.09% Market Closed
Market Cap: ¥138.1B

Wall Street
Price Targets

Price Targets Summary
Takara Bio Inc

Wall Street analysts forecast Takara Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 1 162.8 JPY with a low forecast of 707 JPY and a high forecast of 1 995 JPY.

Lowest
Price Target
707 JPY
38% Downside
Average
Price Target
1 162.8 JPY
1% Upside
Highest
Price Target
1 995 JPY
74% Upside
Takara Bio Inc Competitors:
Price Targets
VNOM
Viper Energy Partners LP
18% Upside
ACAD
ACADIA Pharmaceuticals Inc
40% Upside
EXPO
Exponent Inc
24% Upside

Revenue
Forecast

7% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Takara Bio Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

Operating Income
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Takara Bio Inc

Net Income
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 13 years the compound annual growth rate for Takara Bio Inc's net income is 0%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Takara Bio Inc's stock price target?
Price Target
1 162.8 JPY

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 1 162.8 JPY with a low forecast of 707 JPY and a high forecast of 1 995 JPY.

What is Takara Bio Inc's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Takara Bio Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett